Neuroscience

Articles and news from the latest research reports.

Posts tagged science

0 notes

Why the Middle Finger Has Such a Slow Connection

ScienceDaily (Feb. 7, 2012) — Each part of the body has its own nerve cell area in the brain -we therefore have a map of our bodies in our heads. The functional significance of these maps is largely unclear. What effects they can have is now shown by RUB neuroscientists through reaction time measurements combined with learning experiments and “computational modelling.” They have been able to demonstrate that inhibitory influences of neighbouring “finger nerve cells” affect the reaction time of a finger. The fingers on the outside — i.e. the thumb and little finger — therefore react faster than the middle finger, which is exposed to the “cross fire” of two neighbours on each side. Through targeted learning, this speed handicap can be compensated.

The working group led by PD Dr. Hubert Dinse (Neural Plasticity Lab at the Institute for Neuroral Computation) report in the current issue of PNAS.

Thumb and little finger are the quickest

The researchers set subjects a simple task to measure the speed of decision: they showed them an image on a monitor that represented all ten fingers. If one of the fingers was marked, the subjects were to press a corresponding key as quickly as possible with that finger. The thumb and little finger were the fastest. The middle finger brought up the rear. “You might think that this has anatomical reasons or depends on the exercise” said Dr Dinse, “but we were able to rule that out through further tests. In principle, each finger is able to react equally quickly. Only in the selection task, the middle finger is at a distinct disadvantage.”

Computer simulation depicts brain maps

To explain their observations, the researchers used computer simulations based on a so-called mean-field model. It is especially suited for modelling large neuronal networks in the brain. For these simulations, each individual finger is represented by a group of nerve cells, which are arranged in the form of a topographic map of the fingers based on the actual conditions in the somatosensory cortex of the brain. “Adjacent fingers are adjacent in the brain too, and thus also in the simulation,” explained Dr. Dinse. The communication of the nerve cells amongst themselves is organised so that the nerve cells interact through mutual excitation and inhibition.

Inhibitory influences from both sides slow down the middle finger

The computer simulations showed that the longer reaction time of the middle finger in a multiple choice task is a consequence of the fact that the middle finger is within the inhibition range of the two adjacent fingers. The thumb and little finger on the other hand only receive an inhibitory effect of comparable strength from one adjacent finger each. “In other words, the high level of inhibition received by the nerve cells of the middle fingers mean that it takes longer for the excitement to build up — they therefore react more slowly” said Dr. Dinse.

Targeted reduction of the inhibition through learning

From the results of the computer simulation it can be concluded that weaker inhibition from the neighbouring fingers would shorten the reaction time of the middle finger. This would require a so-termed plastic change in the brain — a specialty of the Neural Plasticity Lab, which has been studying the development of learning protocols that induce such changes for years. One such protocol is the repeated stimulation of certain nerve cell groups, which the laboratory has already used in many experiments. “If, for example, you stimulate one finger electrically or by means of vibration for two to three hours, then its representation in the brain changes” explained Dr. Dinse. The result is an improvement in the sense of touch and a measurable reduction of the inhibitory processes in this brain area. This also results in the enlargement of the representation of the finger stimulated.

Second experiment confirms the prediction

The Bochum researchers then conducted a second experiment in which the middle finger of the right hand was subjected to such stimulation. The result was a significant shortening of the reaction time of this finger in the selection task. “This finding confirms our prediction” Dr. Dinse summed up. Thus, for the first time, Bochum’s researchers have established a direct link between the so-called lateral inhibitory processes and decision making processes. They have shown that learning processes that change the cortical maps can have far-reaching implications not only for simple discrimination tasks, but also for decision processes that were previously attributed to the so-called “higher” cortical areas. 

Source: ScienceDaily

Filed under science neuroscience psychology

0 notes

Sharp Images from the Living Mouse Brain

February 6th, 2012

This STED image of a nerve cell in the upper brain layer of a living mouse shows in previously impossible detail the very fine dendritic protrusions of a nerve cell, the so-called spines, at which the synapses are located. The inset shows the mushroom-shaped head of such a dendritic spine at which the nerve cells receive information from their peers. © Max Planck Institute for Biophysical Chemistry

Source: Neuroscience News

Filed under science neuroscience psychology brain

0 notes

It’s not solitaire: Brain activity differs when one plays against others

February 6, 2012

Rock, paper or scissors? Learning while playing a strategic game against others involves a different pattern of brain activity than learning from the consequences of one’s own actions, researchers found. Credit: L. Brian Stauffer

Researchers have found a way to study how our brains assess the behavior – and likely future actions – of others during competitive social interactions. Their study, described in a paper in the Proceedings of the National Academy of Sciences, is the first to use a computational approach to tease out differing patterns of brain activity during these interactions, the researchers report.

"When players compete against each other in a game, they try to make a mental model of the other person’s intentions, what they’re going to do and how they’re going to play, so they can play strategically against them," said University of Illinois postdoctoral researcher Kyle Mathewson, who conducted the study as a doctoral student in the Beckman Institute with graduate student Lusha Zhu and economics professor and Beckman affiliate Ming Hsu, who now is at the University of California, Berkeley. "We were interested in how this process happens in the brain."

Previous studies have tended to consider only how one learns from the consequences of one’s own actions, called reinforcement learning, Mathewson said. These studies have found heightened activity in the basal ganglia, a set of brain structures known to be involved in the control of muscle movements, goals and learning. Many of these structures signal via the neurotransmitter dopamine.

"That’s been pretty well studied and it’s been figured out that dopamine seems to carry the signal for learning about the outcome of our own actions," Mathewson said. "But how we learn from the actions of other people wasn’t very well characterized."

Researchers call this type of learning “belief learning.”

To better understand how the brain processes information in a competitive setting, the researchers used functional magnetic resonance imaging (fMRI) to track activity in the brains of participants while they played a competitive game, called a Patent Race, against other players. The goal of the game was to invest more than one’s opponent in each round to win a prize (a patent worth considerably more than the amount wagered), while minimizing one’s own losses (the amount wagered in each trial was lost). The fMRI tracked activity at the moment the player learned the outcome of the trial and how much his or her opponent had wagered.

A computational model evaluated the players’ strategies and the outcomes of the trials to map the brain regions involved in each type of learning.

"Both types of learning were tracked by activity in the ventral striatum, which is part of the basal ganglia," Mathewson said. "That’s traditionally known to be involved in reinforcement learning, so we were a little bit surprised to see that belief learning also was represented in that area."

Belief learning also spurred activity in the rostral anterior cingulate, a structure deep in the front of the brain. This region is known to be involved in error processing, regret and “learning with a more social and emotional flavor,” Mathewson said.

The findings offer new insight into the workings of the brain as it is engaged in strategic thinking, Hsu said, and may aid the understanding of neuropsychiatric illnesses that undermine those processes.

"There are a number of mental disorders that affect the brain circuits implicated in our study," Hsu said. "These include schizophrenia, depression and Parkinson’s disease. They all affect these dopaminergic regions in the frontal and striatal brain areas. So to the degree that we can better understand these ubiquitous social functions in strategic settings, it may help us understand how to characterize and, eventually, treat the social deficits that are symptoms of these diseases."

Provided by University of Illinois at Urbana-Champaign

Source: medicalxpress.com

Filed under science neuroscience brain psychology

0 notes

Magnetic research for better brain health

February 6, 2012

A pioneering therapy that uses magnetic pulses to stimulate the brain to treat conditions such as Parkinson’s disease, depression, schizophrenia, epilepsy and stroke is now better understood thanks to researchers from The University of Western Australia and the Université Pierre et Marie Curie in France.

Research Associate Professor Jennifer Rodger from UWA’s School of Animal Biology said she and her team tested the therapy - known as repetitive transcranial magnetic stimulation (rTMS) - on mice to find out how it can be applied to treating human neurological disease.

The research was published recently in the prestigious journal FASEB.

"Our work demonstrated for the first time that pulsed magnetic fields promote changes in brain chemicals that correct abnormal brain connections, resulting in improved behaviour and brain function," joint lead author Dr Rodger said.

"rTMS is an exciting therapy that stimulates the brain. It has shown promising results in treating the damaged human brain. Our research helps to explain how this therapy works on the cells of the brain. Previously, evidence of its usefulness was mainly from anecdotal clinical evidence.

"Our results greatly increase our understanding of the specific cellular and molecular events that occur in the brain during rTMS therapy. We are the first to show that changes in brain circuits underpin these beneficial effects. Our results have implications for how rTMS is used in humans to treat disease and improve brain function."

Dr Rodger explained that the structural and functional changes caused by the therapy in malfunctioning circuits were not seen in the normal healthy brain, suggesting that the therapy could have minimal side effects in humans.

Provided by University of Western Australia

Source: medicalxpress.com

Filed under science neuroscience psychology brain

1 note

Magnetic therapy becoming more popular for treating depression

February 6, 2012

(Medical Xpress) — A new magnetic therapy that treats major depression recently received a major boost when the government announced Medicare will cover the procedure in Illinois.

The treatment, called transcranial magnetic stimulation (TMS), sends short pulses of magnetic fields to the brain. TMS “is rapidly gaining momentum” said Dr. Murali Rao of Loyola University Medical Center, one of the first Chicago-area centers to offer TMS. There now are nearly 300 such centers in the United States.

At Loyola, about two-thirds of Rao’s TMS patients so far report that their depression has significantly lessened or gone away completely.

Before receiving TMS, Nan Miller had failed nine antidepressants and suffered increasingly severe cycles of depression over seven years. There were times when she couldn’t get out of bed or eat. “I just wanted to die,” she said. She had even tried electroconvulsive therapy (formerly known as electroshock) but did not want to consider that option anymore.

Miller said that a few weeks after beginning TMS treatments, she was eating lunch when she suddenly realized depression did not consume her anymore. “I could almost hear the chains breaking, the darkness lifting and the heaviness dissolving,” she said. “I feel about 10 years younger and 20 shades lighter.”

The Food and Drug Administration approved TMS in 2009 for patients who have major depression and have failed at least one antidepressant. The FDA has approved one TMS system, NeuroStar®, made by Neuronetics.

The patient reclines in a comfortable padded chair. A magnetic coil, placed next to the left side of the head, sends short pulses of magnetic fields to the surface of the brain. This produces currents that stimulate brain cells. The currents, in turn, affect mood-regulatory circuits deeper in the brain. The resulting changes in the brain appear to be beneficial to patients who suffer depression.

Each treatment lasts 35 to 40 minutes. Patients typically undergo three treatments per week for four to six weeks.

The treatments do not require anesthesia or sedation. Afterward, a patient can immediately resume normal activities, including driving. Studies have found that patients do not experience memory loss or seizures. Side effects include mild headache or tingling in the scalp, which can be treated with Tylenol.

Together, psychotherapy and antidepressants successfully treat only about one-third of patients who suffer major depression. TMS is a noninvasive treatment option now available for the other two-thirds of patients, who experience only partial relief from depression or no relief at all, Rao said.

Provided by Loyola University Health System

Source: medicalxpress.com

Filed under science neuroscience psychology depression

1 note

DNA Test that Identifies Down Syndrome in Pregnancy Can Also Detect Trisomy 18 and Trisomy 13

February 2nd, 2012

A newly available DNA-based prenatal blood test that can identify a pregnancy with Down syndrome can also identify two additional chromosome abnormalities: trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome).The test for all three defects can be offered as early as 10 weeks of pregnancy to women who have been identified as being at high risk for these abnormalities.

These are the results of an international, multicenter study published on-line today in the journal Genetics in Medicine. The study, the largest and most comprehensive done to date, adds to the documented capability (study published in Genetics in Medicine in October 2011) of the tests by examining results in 62 pregnancies with trisomy 18 and 12 pregnancies with trisomy 13.Together with the Down syndrome pregnancies reported earlier, 286 trisomic pregnancies and 1,702 normal pregnancies are included in the report.

The research was led by Glenn Palomaki, PhD, and Jacob Canick, PhD, of the Division of Medical Screening and Special Testing in the Department of Pathology and Laboratory Medicine at Women & Infants Hospital of Rhode Island and The Warren Alpert Medical School of Brown University, and included scientists at Sequenom Inc. and Sequenom Center for Molecular Medicine, San Diego, CA, and an independent academic laboratory at the University of California at Los Angeles.

The test identified 100% (59/59) of the trisomy 18 and 91.7% (11/12) of the trisomy 13 pregnancies.The associated false positive rates were 0.28 and 0.97%, respectively.Overall, testing failed to provide a clinical interpretation in 17 women (0.9%); three of these women had a trisomy 18 pregnancy.By slightly raising the definition of a positive test for chromosome 18 and 13, the detection rate remained constant, but the false positive rate could be as low as 0.1%.These findings, along with the detailed information learned from testing such a large number of samples, demonstrate that the new test will be highly effective when offered to women considering invasive testing.

“Our previous work demonstrated the ability to identify Down syndrome, the most common trisomy.These new data extend the finding to the next two most common trisomies and will allow for wider use of such testing with the ability to identify all three common trisomies,” said Dr. Palomaki.”The new DNA test can now also be offered to women identified as being as high risk for trisomy 18 or trisomy 13, as well those at high risk for Down syndrome.”

“This highly sensitive and specific DNA test has the potential to impact on couples’ decision-making,” says Dr. Canick.”A woman whose pregnancy was identified as high risk who earlier would have chosen not to have invasive diagnostic testing, might now consider the DNA test as a safe way to obtain further information, before making a final decision.”The US Centers for Disease Control and Prevention estimated in 1995 that about one in every 200 invasive diagnostic procedures will cause a pregnancy miscarriage.

Trisomy 18, also called Edwards syndrome, is a serious disorder with up to 70% of first trimester affected fetuses being spontaneously lost during pregnancies.Among those born alive, half die within a week with only 5% surviving the first year.All have serious medical and developmental problems.About 1,330 infants with trisomy 18 would be born in the US each year in the absence of prenatal diagnosis.Trisomy 13, also called Patau syndrome, is less common but equally serious.About 600 infants with trisomy 13 would be born in the US each year in the absence of prenatal diagnosis.Like Down syndrome, trisomy 18 and trisomy 13 are more common as maternal age increases.For comparison, about 7,730 Down syndrome cases would be born each year in the absence of prenatal diagnosis.Current prenatal screening tests for trisomy 18 and trisomy 13 rely on both biochemical and ultrasound markers.For more information visit the US National Library of Medicine PubMed Health.

This industry-sponsored project, awarded to Drs. Palomaki and Canick and Women & Infants Hospital in 2008, enrolled 4,500 women at 27 prenatal diagnostic centers throughout the world.Women & Infants also served as one of the enrollment centers under the direction of maternal-fetal medicine specialist and director of Perinatal Genetics, Barbara O’Brien, MD.

“It is clinically more relevant that all three trisomies can be detected by this test,” said Dr. O’Brien.”Having access to such a comprehensive, DNA-based test that can be done early in pregnancy will give us more information so that we can better guide which patients should consider diagnostic testing.”

Women & Infants Hospital has been an international center for prenatal screening research. For more than three decades, Drs. Palomaki and Canick have collaborated with others in developing and improving screening tests for Down syndrome and other fetal abnormalities.In 1988, Drs. Palomaki and Canick were involved in the development of triple marker screening. The team was able to convert its findings into prenatal screening tests now used throughout the world.Dr. Canick’s lab in 1998 was the first in the US to offer quad marker screening and in the past decade was the laboratory center for the NIH-funded FASTER Trial which compared first and second trimester screening.

Source: Neuroscience News

Filed under science neuroscience psychology genetics

5 notes

Gender Specific Behavior Traced To Hormone-Controlled Genes In The Brain

Article Date: 06 Feb 2012 - 0:00 PST

Men and women may be equals, but they often behave differently when it comes to sex and parenting. Now a study of the differences between the brains of male and female mice in the Cell Press journal Cell provides insight into how our own brains might be programmed for these stereotypically different behaviors.

The new evidence shows that the sex hormones - testosterone, estrogen, and progesterone - act in a key region of the brain, switching certain genes on and others off. When the researchers tinkered with each of these genes one by one, animals showed subtle but important shifts in individual sex-specific behaviors, such as how males mate or females care for their pups.

“What this means is that complex behaviors like male mating or maternal care in mice can be deconstructed at the genetic level,” said Nirao Shah of the University of California, San Francisco. The findings present a cellular and molecular representation of gender that is remarkable in its complexity, the researchers say.

Shah’s team made these discoveries after screening mouse brains for genes that show differences in expression in males versus females. The researchers focused specifically on the hypothalamus, a region previously implicated in the control of sex-specific behaviors. Their screen produced a list of 16 genes with clear sex differences in distinct neurons in the hypothalamus. Surprisingly, Shah’s team found that many of these genes also show sex differences in the amygdala, a part of the brain important for emotions.

In further studies, the researchers examined the effects of a subset of these individual genes. Mice missing only one of these 16 genes seemed to behave normally. But upon closer observation, these mice showed significant differences in sex-specific behaviors. For instance, Shah explained, females mutant for one gene took longer to return their pups to the nest and to fight off intruders. “They still take care of their pups, but less effectively,” he said.

In other experiments, deletion of a single gene produced females that were two-fold less receptive to mating with males. Similarly, males mutant for another gene were less interested in females. Together these results mean that sex-specific behaviors can be controlled in modular fashion, such that the loss of any one gene leads to subtle but potentially important changes.

“At the superficial level, the mice appear normal, but this is pretty significant variation in behavior,” Shah said. It suggests that variation in such genes might explain not just differences between the sexes, but also differences in behaviors within one sex or the other - why some male mice are more aggressive than other males or some females more attentive to their offspring than other females.

The researchers don’t yet know exactly how these differences in gene expression lead to those differences in behavior, although Shah says some of the genes are known to be involved in sending or receiving neural messages in the brain. It also remains to be seen how the male and female gene expression programs might be influenced by the animals’ social interactions and experiences.

There is still a lot to learn about what makes males and females tick. “This gene list of sex differences in the brain is probably just a small subset of what we will eventually unearth,” Shah said.  

Source: Medical News Today

Filed under science neuroscience psychology genetics brain

0 notes

Memory Function - Decaffeinated Coffee May Help

Article Date: 05 Feb 2012 - 0:00 PST

Drinking decaffeinated coffee may improve brain energy metabolism associated with diabetes type 2, according to a study published in Nutritional Neuroscience and carried out by researchers at Mount Sinai School of Medicine. Brain energy metabolism is a dysfunction with a known risk factor for dementia and other neurodegenerative disorders like Alzheimer’s disease.

Giulio Maria Pasinetti, MD, PhD, and team decided to investigate whether dietary supplementation with a standard decaffeinated coffee prior to diabetes onset could improve insulin resistance and glucose utilization in mice with diet-induced type 2 diabetes.

The mice were given the supplement for five months, after which the researchers assessed the animals’ brain’s genetic response. They discovered that the brain could metabolize glucose more effectively and that it was used for cellular energy in the brain. People with type 2 diabetes have reduced glucose utilization in the brain, which often leads to neurocognitive problems.

Dr. Pasinetti stated:

"Impaired energy metabolism in the brain is known to be tightly correlated with cognitive decline during aging and in subjects at high risk for developing neurodegenerative disorders. This is the first evidence showing the potential benefits of decaffeinated coffee preparations for both preventing and treating cognitive decline caused by type 2 diabetes, aging, and/or neurodegenerative disorders."



Drinking coffee is not recommended for everyone, because of its association with cardiovascular health risks, including elevated blood cholesterol and blood pressure, both of which result in a higher risk of developing heart disease, stroke, and premature death. However, these negative effects have mainly been caused because of the high caffeine content of coffee - the study findings prove that some components in decaffeinated coffee have beneficial health factors for mice.

Dr. Pasinetti wants to investigate whether decaffeinated coffee as a dietary supplement in humans can act as a preventive measure.

He concludes:

"In light of recent evidence suggesting that cognitive impairment associated with Alzheimer’s disease and other age-related neurodegenerative disorders may be traced back to neuropathological conditions initiated several decades before disease onset, developing preventive treatments for such disorders is critical."


Petra Rattue 

Source: Medical News Today

Filed under science neuroscience psychology brain memory

free counters